Method for the clinical separation of .alpha.- and .beta.-lipoproteins
AssigneeSymphar S.A.
InventorCraig L. Bentzen
Life of this patent
Estimating the term…
Loading patent…
AssigneeSymphar S.A.
InventorCraig L. Bentzen
Estimating the term…
This invention relates to a separation method comprising the introduction of a sample of serum or plasma into a microcolumn containing a support which has a sulfated polysaccharide, preferably heparin, covalently bound to it so as to remove from said sample the .beta.-lipoproteins by binding thereof to this ligand, followed by washing the microcolumn with a first pH buffered solution and collecting the eluant representing a first fraction containing the .alpha.-lipoprotein portion of the sample. Then the microcolumn is washed wth a second pH buffered solution so as to release the ligand-bound .beta.-lipoproteins and to recover a second fraction containing the .beta.-lipoprotein portion of the sample. Afterwards, it is possible to separately determine the .alpha.- and .beta.-lipoprotein-cholesterol, as well as the respective .alpha./.beta. ratios of phospholipids, triglycerides and various apoproteines, and to calculate the respective ratios .alpha./.beta., all useful as clinical diagnostic indexes and allowing to obtain a complete lipoprotein profiling. The invention also concerns a kit comprising in a transportable box all the implements and reagents duly prepared so as to easily and quickly carry out the above method.
A method for the clinical separation of .alpha.-lipoproteins from .beta.-lipoproteins and for the determination of the ratio of .alpha.-lipoproteins to .beta.-lipoproteins in serum or plasma free from added divalent cations, comprising introducing a sample of serum or plasma free from added divalent cations into a microcolumn containing heparin bound to agarose so as to remove from said sample the .beta.-lipoproteins by binding thereof to this ligand, washing the microcolumn with a first pH-buffered solution free from added divalent cations and collecting the eluant as a first fraction containing the .alpha.-lipoprotein portion of the sample, subsequently washing the microcolumn with a second pH-buffered solution free from added divalent cations that releases the ligand-bound .beta.-lipoproteins and collecting the eluant as a second fraction containing the .beta.-lipoprotein portion of the sample, analyzing the first fraction for .alpha.-lipoprotein, analyzing the second fraction for .beta.-lipoprotein, and using said analyses to calculate the ratio of .alpha.-lipoproteins and .beta.-lipoproteins in said sample.
Dependencies are inferred from the claim text.